252 related articles for article (PubMed ID: 20012392)
1. Engineering the mouse genome to model human disease for drug discovery.
Koentgen F; Suess G; Naf D
Methods Mol Biol; 2010; 602():55-77. PubMed ID: 20012392
[TBL] [Abstract][Full Text] [Related]
2. Genetic engineering in the mouse: tuning TNF/TNFR expression.
Douni E; Alexiou M; Kollias G
Methods Mol Med; 2004; 98():137-70. PubMed ID: 15064438
[TBL] [Abstract][Full Text] [Related]
3. Genetically engineered mouse models in drug discovery research.
Sacca R; Engle SJ; Qin W; Stock JL; McNeish JD
Methods Mol Biol; 2010; 602():37-54. PubMed ID: 20012391
[TBL] [Abstract][Full Text] [Related]
4. Engineering chromosomal rearrangements in mice.
Yu Y; Bradley A
Nat Rev Genet; 2001 Oct; 2(10):780-90. PubMed ID: 11584294
[TBL] [Abstract][Full Text] [Related]
5. Teaching molecular genetics: chapter 2-Transgenesis and gene targeting: mouse models to study gene function and expression.
Claij N; Peters DJ
Pediatr Nephrol; 2006 Mar; 21(3):318-23. PubMed ID: 16395602
[TBL] [Abstract][Full Text] [Related]
6. [Application and recent advances of laboratory mouse in human cancer research].
Liu EQ; Kitajima S; Morimoto M
Ai Zheng; 2005 Feb; 24(2):249-54. PubMed ID: 15694046
[TBL] [Abstract][Full Text] [Related]
7. [Genetically engineered mice and its application to bioindustry].
Koda T; Togashi Y; Nishimura T
Hokkaido Igaku Zasshi; 2002 Mar; 77(2):151-6. PubMed ID: 11968850
[TBL] [Abstract][Full Text] [Related]
8. Current issues in mouse genome engineering.
Glaser S; Anastassiadis K; Stewart AF
Nat Genet; 2005 Nov; 37(11):1187-93. PubMed ID: 16254565
[TBL] [Abstract][Full Text] [Related]
9. Engineering embryonic stem cells with recombinase systems.
Schnütgen F; Stewart AF; von Melchner H; Anastassiadis K
Methods Enzymol; 2006; 420():100-36. PubMed ID: 17161696
[TBL] [Abstract][Full Text] [Related]
10. Animal transgenesis: an overview.
Gama Sosa MA; De Gasperi R; Elder GA
Brain Struct Funct; 2010 Mar; 214(2-3):91-109. PubMed ID: 19937345
[TBL] [Abstract][Full Text] [Related]
11. Modeling cancer in mice.
Jackson-Grusby L
Oncogene; 2002 Aug; 21(35):5504-14. PubMed ID: 12154411
[TBL] [Abstract][Full Text] [Related]
12. Practical development of genetically engineered animals as human disease models.
Nomura T
Lab Anim Sci; 1997 Apr; 47(2):113-7. PubMed ID: 9150486
[TBL] [Abstract][Full Text] [Related]
13. Delivery and mechanistic considerations for the production of knock-in mice by single-stranded oligonucleotide gene targeting.
Murphy BR; Moayedpardazi HS; Gewirtz AM; Diamond SL; Pierce EA
Gene Ther; 2007 Feb; 14(4):304-15. PubMed ID: 17024103
[TBL] [Abstract][Full Text] [Related]
14. BAC to immunology--bacterial artificial chromosome-mediated transgenesis for targeting of immune cells.
Sparwasser T; Eberl G
Immunology; 2007 Jul; 121(3):308-13. PubMed ID: 17437533
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous and engineered mutant mice as models for experimental and comparative pathology: history, comparison, and developmental technology.
Roths JB; Foxworth WB; McArthur MJ; Montgomery CA; Kier AB
Lab Anim Sci; 1999 Feb; 49(1):12-34. PubMed ID: 10090091
[TBL] [Abstract][Full Text] [Related]
16. A versatile tool for conditional gene expression and knockdown.
Szulc J; Wiznerowicz M; Sauvain MO; Trono D; Aebischer P
Nat Methods; 2006 Feb; 3(2):109-16. PubMed ID: 16432520
[TBL] [Abstract][Full Text] [Related]
17. Recent innovations in tissue-specific gene modifications in the mouse.
Furuta Y; Behringer RR
Birth Defects Res C Embryo Today; 2005 Mar; 75(1):43-57. PubMed ID: 15838923
[TBL] [Abstract][Full Text] [Related]
18. Engineering the mouse genome with bacterial artificial chromosomes to create multipurpose alleles.
Testa G; Zhang Y; Vintersten K; Benes V; Pijnappel WW; Chambers I; Smith AJ; Smith AG; Stewart AF
Nat Biotechnol; 2003 Apr; 21(4):443-7. PubMed ID: 12627172
[TBL] [Abstract][Full Text] [Related]
19. Transgene expression and RNA interference in embryonic stem cells.
Zaehres H; Daley GQ
Methods Enzymol; 2006; 420():49-64. PubMed ID: 17161693
[TBL] [Abstract][Full Text] [Related]
20. Disease research and drug development models based on genetically altered human embryonic stem cells.
Song H; Xu Y
Discov Med; 2010 Jun; 9(49):500-3. PubMed ID: 20587338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
